Clinical Trial Update: Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of inhaled Frespaciguat (MK-5475) in adults with pulmonary hypertension associated with chronic obst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• Frespaciguat

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING